By Ahmed El-Medany Presented by Professor Michele Brignole, San Luca Hospital, Milan, APAF-CRT was a two-phase trial in individuals with severely symptomatic atrial fibrillation (AF)…
View More Highlights from Day 2 of the ESC 2021 congress – APAF-CRT
The ENVISAGE-TAVI AF trial demonstrated that Edoxaban’s non-inferiority to warfarin with regards to myocardial infarction (MI), ischaemic stroke, systemic thromboembolism, and valve thrombosis, in participants…
View More Highlights from Day 2 of the ESC 2021 congress – ENVISAGE-TAVI AF
Presented by Dr. Marco Valgimigli, the MASTER DAPT trial assessed whether 1 month of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI), with a…
View More Highlights from Day 2 of the ESC 2021 congress – MASTER DAPT
By Ahmed El-Medany As usual, there were a multitude of fascinating trials presented at the Hot Line session at the ESC Congress 2021. Professor Axel…
View More Highlights from Day 1 of the ESC congress – SMART-MI
By Ahmed El-Medany The 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (HF) were published on the 27th of…
View More New 2021 ESC Guidelines for the diagnosis and management of heart failure published
Meetings and courses to remain online during COVID-19 pandemic
View More ESC Congress 2021 to Be Held Online